Precision Diagnostics Market Report 2026

Precision Diagnostics Market Overview

• Precision Diagnostics market size has reached to $110.94 billion in 2025 • Expected to grow to $220.51 billion in 2030 at a compound annual growth rate (CAGR) of 14.8% • Growth Driver: Precision Diagnostics Market Thrives On The Surge In Chronic Disease Prevalence • Market Trend: Innovative AI-Driven Video Analysis Tools Revolutionize Understanding of Medical Data in Precision Diagnostics • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Precision Diagnostics Market?

Precision diagnostics refers to a subspecialty of precision medicine that provides healthcare leveraging individual data, such as genetic, environmental, and lifestyle information, to enhance illness prevention, diagnosis, and treatment. It is employed to provide more genetic information about a patient's clinical history for studies that may benefit the treatment process. The main types of precision diagnostics are genetic tests, esoteric tests, and others. Genetic tests refer to laboratory tests to look for differences in an individual's DNA such as alterations to a person's chromosomes, genes, or gene expression in their cells or tissues. The various technologies include next-generation sequencing (NGS), polymerase chain reaction (PCR), in situ hybridization (ISH), mass spectrometry, immunohistochemistry (IHC), and others. These are used in various applications such as oncology, infectious diseases, cardiovascular, neurology, and genetic disorders, and others and are used by hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and others.

What Is The Precision Diagnostics Market Growth Forecast?

The precision diagnostics market size is expected to see rapid growth in the next few years. It will grow to $220.51 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing demand for individualized treatment planning, rising investments in genomic diagnostics, expansion of liquid biopsy applications, growing integration of ai-driven diagnostics, increasing focus on preventive healthcare. Major trends in the forecast period include increasing adoption of genetic and molecular testing, rising use of companion diagnostics, growing integration of ai in diagnostic interpretation, expansion of precision oncology applications, enhanced focus on early disease detection.

What Is The Driver Of The Precision Diagnostics Market?

The rising prevalence of chronic diseases is expected to propel the growth of the precision diagnostics market going forward. A chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Precision diagnostics help patients suffering from chronic diseases such as cancer and cardiovascular diseases by precisely managing a patient's healthcare model and diagnosing the disease with accurate results. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition would increase to 142.66 million by 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the precision diagnostics industry.

Key Players In The Global Precision Diagnostics Market

Major companies operating in the precision diagnostics market are F Hoffmann La Roche Ltd, Abbott Laboratories, Danaher Corporation, Becton Dickinson And Company, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Siemens Healthineers AG, Agilent Technologies Inc, PerkinElmer Inc, Beckman Coulter Inc, Charles River Laboratories International Inc, Sysmex America Inc, Waters Corporation, Bio Rad Laboratories Inc, Bruker Corporation, Qiagen NV, Bio Techne Corporation, Illumina Inc, Luminex Corporation, BioFire Diagnostics LLC, Genomic Health Inc, Guardant Health Inc, Natera Inc, Exact Sciences Corporation

Global Precision Diagnostics Market Trends and Insights

Major companies operating in the precision diagnostics market are focusing on innovative therapy. Introductions such as AI-driven video analysis tools to enhance patient engagement and improve understanding of complex medical data, ultimately empowering individuals to take charge of their health. An AI-driven video analysis tool uses artificial intelligence to process video content, simplifying complex information such as health reports by highlighting key parameters, thus providing clear insights for better understanding and informed decision-making. For instance, in August 2024, Healthians, an India-based diagnostic company, introduced an industry-first AI-driven video analysis tool that simplifies complex medical data by highlighting key health parameters and explaining their significance, effectively guiding users through their health reports. This innovative feature allows users to receive personalized insights within 15-30 minutes after completing a brief questionnaire on the Healthians app, enhancing their ability to make informed decisions about their health.

What Are Latest Mergers And Acquisitions In The Precision Diagnostics Market?

In February 2024, Myriad Genetics, a US-based molecular diagnostics company, acquired Intermountain Precision Genomics (IPG) for an undisclosed amount. Through this acquisition, it aims to enhance its tumor-profiling capabilities and expand precision oncology testing offerings, including advanced solid tumor and liquid biopsy genomic analyses. Intermountain Precision Genomics is a US-based laboratory specializing in DNA- and RNA-based tumor testing, providing CLIA-certified genomic profiling solutions for clinical and research applications in oncology.

What Defines the Precision Diagnostics Market?

The precision diagnostics market consists of revenues earned by entities by providing precision imaging, molecular imaging, on-device X-ray AI algorithms, and automated MR workflow. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision diagnostics market also includes sales of medical diagnostic kits, rapid test kits, instruments and analyzers, and diagnostic equipment that are used in precision diagnostics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Precision Diagnostics Market Report 2026?

The precision diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the precision diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.